Skip to main content
. 2020 Dec 26;3(4):532–548. doi: 10.1016/j.cjco.2020.11.022

Table 1.

Best evidence studies describing the initial presenting manifestation of cardiac sarcoidosis

Reference Patient group Main initial presentation
AVB VT HF SCD Others
Ekstrom et al.15 Nationwide registries (1998-2015), n = 351 42 14 17 14 14
Nordenswan et al.16 Nationwide registries (1988-2015), n = 325 44 13 15 14 14
Fussner et al.12 2 academic medical centres in Minnesota and Calgary (1994-2014), n = 91 34 24 52 N/A 15
Kandolin et al.9 22 hospitals in Finland (1988-2012), n = 110 44 28 18 5 6
Kandolin et al.10 Single centre (2000-2010), n = 55 47 29 16 4 4

Data are given in percentages.

AVB, atrioventricular block; HF, heart failure; N/A, not available; SCD, sudden cardiac death; VT, ventricular tachycardia.

Twenty patients had more than 1 feature at presentation.